-
Endo To Enter A Year Of Recovery Following FDA Request To Pull Opana ER Off The Market
Friday, June 9, 2017 - 9:49am | 345Shares of Endo International plc - Ordinary Shares (NASDAQ: ENDP) were trading lower by more than 10 percent Friday morning in reaction to the U.S. Food and Drug Administration's request for the company to withdraw from the market its opioid painkiller called Opana ER. Stifel's Annabel Samimy felt...